Shigeki Makino

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Photocatalytic Degradation of 4-n-Nonylphenol under Irradiation from Solar Simulator: Comparison between BiVO4 and TiO2 Photocatalysts

Shigeru Kohtani, Shigeki Makino, Akihiko Kudo et al. · Chemistry Letters · 2002 · 136 citations

Natural Sciences, Environmental Engineering, Environmental Sciences +17

Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients

Youhei Fujiki, Takuya Kotani, Kentaro Isoda et al. · Modern Rheumatology · 2017 · 98 citations

Medicine, Clinical Sciences, Oncology +16

Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis.

Takuya Kotani, Shigeki Makino, Tohru Takeuchi et al. · PubMed · 2008 · 87 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients

Shuzo Yoshida, Tohru Takeuchi, Takuya Kotani et al. · Journal of Human Hypertension · 2013 · 86 citations

Medicine, Immunology, Pharmacotherapy +15